Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Mid-childhood bone mass after exposure to repeat doses of antenatal glucocorticoids: a randomized trial
Author: McKinlay, C.
Cutfield, W.
Battin, M.
Dalziel, S.
Crowther, C.
Harding, J.
Citation: Pediatrics, 2017; 139(5):e20164250-1-e20164250-11
Publisher: American Academy of Pediatrics
Issue Date: 2017
ISSN: 0031-4005
Statement of
Christopher J.D. McKinlay, Wayne S. Cutfield, Malcolm R. Battin, Stuart R. Dalziel, Caroline A. Crowther, Jane E. Harding for the ACTORDS Follow-up Group
Abstract: BACKGROUND AND OBJECTIVE: Treatment of women at risk for preterm birth with repeat doses of glucocorticoids reduces neonatal morbidity, but could have adverse effects on skeletal development. We assessed whether exposure to repeat antenatal betamethasone alters bone mass in children whose mothers participated in the Australasian Collaborative Trial of Repeat Doses of Corticosteroids. METHODS: Women were randomized to a single dose of betamethasone or placebo, ≥7 days after an initial course of glucocorticoids, repeated each week that they remained at risk for preterm birth at <32 weeks’ gestation. In this follow-up study, children underwent whole-body dual-energy radiograph absorptiometry at 6 to 8 years’ corrected age. RESULTS: Of 212 eligible childhood survivors, 185 were studied (87%; 91 repeat betamethasone group; 94 placebo [single course] group). Children exposed to repeat antenatal betamethasone and those exposed to placebo had similar whole-body bone mineral content (median repeat betamethasone: 553 g, interquartile range: 442–712 g; placebo: 567 g, interquartile range: 447–750 g; geometric mean ratio: 0.99; 95% confidence interval: 0.94–1.03, P = .55) and bone area (median repeat betamethasone 832 cm2, interquartile range: 693–963 cm2; placebo: 822 cm2, interquartile range: 710–1020 cm2; geometric mean ratio: 0.99, 95% confidence interval: 0.92–1.07, P = .75). CONCLUSIONS: Exposure to repeat doses of antenatal betamethasone compared with a single course of glucocorticoids does not alter bone mass in mid-childhood.
Keywords: Fetus/newborn infant; fetus/newborn infant; neonatology; gynecology; gynecology; maternal and fetal medicine
Rights: Copyright © 2017 by the American Academy of Pediatrics
DOI: 10.1542/peds.2016-4250
Appears in Collections:Aurora harvest 3
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.